MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver ...
Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) ...
Unaudited Estimated Ranges Consistent with Previous Financial Guidance Raises 2025 Financial Guidance Ranges for Total Revenue to $1,150 - $1,225 million, Representing YoY Growth of 16% - 23%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback